Issue 6, 2017

Synthesis of thioether andrographolide derivatives and their inhibitory effect against cancer cells

Abstract

A series of novel thioether andrographolide derivatives were synthesized by incorporating various aromatic (or heteroaromatic) substituents into C-12 or 14-OH. A total of 38 andrographolide derivatives were prepared and evaluated for their in vitro inhibitory activity against cancer cells. All the derivatives exhibited better activity against prostate cancer cells (PC-3) than the parent compound. Among these, compounds 6a, 8, 9, 17, 19, 31, and 32 demonstrated good activity. These compounds were further evaluated for their anticancer activities against other cancer cell lines including MCF-7, MDA-MB-231, and A549. Compounds 31 and 32 showed excellent activity against MCF-7 with an IC50 value of 0.7 and 0.6 μM, respectively. The absolute configuration of 15a was determined via single-crystal X-ray diffraction. The activity of 6a (12S), which was the precursor of 15a, was better than that of the diastereoisomer 6b (12R). Moreover, the preliminary structure–activity relationship has been summarized. The results obtained herein are very important for further optimization of andrographolide.

Graphical abstract: Synthesis of thioether andrographolide derivatives and their inhibitory effect against cancer cells

Supplementary files

Article information

Article type
Research Article
Submitted
06 Apr 2017
Accepted
25 Apr 2017
First published
28 Apr 2017

Med. Chem. Commun., 2017,8, 1268-1274

Synthesis of thioether andrographolide derivatives and their inhibitory effect against cancer cells

Y. Liu, R. Liang, Q. Ma, K. Xu, X. Liang, W. Huang, R. Sutton, J. Ding, P. M. O'Neil and C. Cheng, Med. Chem. Commun., 2017, 8, 1268 DOI: 10.1039/C7MD00169J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements